Aopia secures seed round investment

Aopia Biosciences secured seed round of investment to support the development and commercialization of NanoEX™, a next-generation extracellular vesicle (EV) isolation and enrichment platform. NanoEX™ is based on the patented asymmetric nanopore membrane (ANM) technology and can deliver unparalleled EV isolation efficiency and purity. This highly scalable platform not only allows fast purification of exosomes […]